Gaxos Health Expands Medical Advisory Board
GlobeNewswire
Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial..
Hormone replacement therapy
News and Video Search Results
News coverage
-
United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism
GlobeNewswire
-
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1
GlobeNewswire
-
Global Testosterone Replacement Therapy Market Size To Worth USD 2.93 Billion By 2033 | CAGR Of 4.0%
GlobeNewswire
-
5-Alpha Reductase Deficiency Global Market Report 2024: A $1.94 Billion Projected Market in 2028
GlobeNewswire
0 shares
1 views
You might like
Hormone replacement therapy media coverage
Episode 10: Barenaked Truth
Rumble
Adam joins this week’s episode to talk about the Satanic influences over music today, his take on how men are able to level up,..
Bag Head Podcast 9
Rumble
Advertisement
More coverage
Hypoparathyroidism Market is Expected to Exhibit Impressive Growth by 2032, Assesses DelveInsight | Leading Companies Developing Therapies - Ascendis Pharma, Amolyt Pharma, Bridgebio, Calcilytix Therapeutics
GlobeNewswire
The hypoparathyroidism market is expected to grow by factors like an increase in the patient pool, and expected entry of emerging..
-
Ascendis Pharma Launches 2nd TransCon™ Product: YORVIPATH® Now Available in Germany and Austria for Adults with Chronic Hypoparathyroidism
Upworthy
-
Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset
Accesswire
-
Peptides Market Projected to Exceed US$ 89.6 Bn by 2033 Driven by Advancement in Peptide Synthesis | Marketresearch.biz
GlobeNewswire
-
Hormone Replacement Therapy Market Surges, to Reach USD 50.5 Billion by 2033 with a 7.8% CAGR
GlobeNewswire